MedTrace Logo

Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)

NCT06502834 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-16

No results posted yet for this study

Summary

The goal of the study is to determine the effect of supplementation of the d piger strain on intestinal ethanol production in individuals with overweight.

The investigators will perform a randomized trial in 2x10 participants to measure effects on ethanol in blood, and perform fecal analyses.

Conditions

  • Obesity
  • Metabolic Syndrome
  • Steatosis of Liver

Interventions

DIETARY_SUPPLEMENT

D piger

Probiotic d piger

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Max Nieuwdorp

    lead OTHER

Principal Investigators

  • Max Nieuwdorp, prof dr · Amsterdam UMC, location AMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06502834 on ClinicalTrials.gov